Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS. Long-acting injectable (LAI) HIV medications are reshaping how ...

Bayesian spatiotemporal modeling showed HOLC grades C and D had significantly lower adjusted screening odds versus grade A, despite no unadjusted grade differences. Median screening prevalence ...

Cardiac diagnoses and all-cause mortality do not carry the same evidentiary weight in an observational study, and Eman A.

An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and ...

Christos Vaklavas, MD, discusses geographic and telehealth barriers to cancer care access across Utah and the broader ...

Among 56,978 Dutch adults, occupational irritants (OR, 1.19), cleaning products (1.25), and mites (1.41) tracked with ...

Ropeginterferon alfa-2b-njft is expected to be available immediately.

Crossover dosing with commercially available THC gummies used a validated marker of lane control as the primary end point, alongside reaction time, speed variability, willingness to drive, perceived ...

In honor of Blood Cancer Awareness Month, this special Director’s Cut episode of Managed Care Cast features a conversation ...

Christos Vaklavas, MD, is a professor and breast cancer oncologist at the University of Utah Huntsman Cancer Institute.

Selinexor achieved a 35% or greater spleen volume reduction in 17% of patients at week 24, and in 23% at any point during ...